Search

Author/Creator Lockshin, Benjamin

1. 338 Laboratory safety from a 16-week phase 3 study of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis. (25th January 2023)

Authors:
Paller, Amy S; Wollenberg, Andreas; Siegfried, Elaine C; Gonzalez, Mercedes E; Lockshin, Benjamin; Khokhar, Faisal A; Chen, Zhen; Gonzalez, Tayler; Prescilla, Randy
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Issue 4 (5th February 2019)

Authors:
Elnabawi, Youssef A; Dey, Amit K; Goyal, Aditya; Groenendyk, Jacob W; Chung, Jonathan H; Belur, Agastya D; Rodante, Justin; Harrington, Charlotte L; Teague, Heather L; Baumer, Yvonne; Keel, Andrew; Playford, Martin P; Sandfort, Veit; Chen, Marcus Y; Lockshin, Benjamin; Gelfand, Joel M; Bluemke, D...
Journal:
Cardiovascular research
Issue:
Volume 115:Issue 4(2019)
Page Start:
721
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry. Issue 2 (15th February 2021)

Authors:
Lockshin, Benjamin; Cronin, Angel; Harrison, Ryan W.; McLean, Robert R.; Anatale‐Tardiff, Laura; Burge, Russel; Zhu, Baojin; Malatestinic, William N.; Atiya, Bilal; Murage, Mwangi J.; Gallo, Gaia; Strober, Bruce; Van Voorhees, Abby
Journal:
Dermatologic therapy
Issue:
Volume 34:Issue 2(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10356 (17th September 2022)

Authors:
Paller, Amy S; Simpson, Eric L; Siegfried, Elaine C; Cork, Michael J; Wollenberg, Andreas; Arkwright, Peter D; Soong, Weily; Gonzalez, Mercedes E; Schneider, Lynda C; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; ...
Journal:
Lancet
Issue:
Volume 400:Issue 10356(2022)
Page Start:
908
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis. (19th May 2022)

Authors:
Blauvelt, Andrew; Gordon, Kenneth B.; Lee, Patricia; Bagel, Jerry; Sofen, Howard; Lockshin, Benjamin; Soliman, Ahmed M.; Geng, Ziqian; Zhan, Tianyu; Alperovich, Gabriela; Stein Gold, Linda
Journal:
Journal of dermatological treatment
Issue:
Volume 33:Number 4(2022)
Page Start:
2085
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗